Condition: Breast Cancer · Sponsor: Centre Georges Francois Leclerc
This study aims to constitute a most complete biological collection for patients treated for localized or metastatic breast cancer (in different cohorts depending on the type of systemic treatment received), in order to describe the basal immune response of patients treated for a breast cancer according to the stage of the disease, but above all to study how the different systemic treatments used in the management of breast cancer modulate this immune response.
This description comes directly from the study's public registry record.
Sylvain LADOIRE, PU-PH · 03 80 73 75 28 · sladoire@cgfl.fr
Emilie REDERSTORFF · erederstorff@cgfl.fr
Always discuss trial participation with your own doctor first.
| CHRU Jean Minjoz | Besançon, France | Not Yet Recruiting |
| Centre Georges Francois Leclerc | Dijon, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04925856